+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

5G-enabled Medical Devices Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 192 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5716124
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The 5G-enabled medical devices market is transforming healthcare delivery by enabling faster, more reliable clinical connectivity. Senior decision-makers are using these innovations to optimize workflows, improve response times, and prepare their organizations for emerging opportunities in a changing digital landscape.

Market Snapshot: 5G-Enabled Medical Devices Market Size & Growth

The global 5G-enabled medical devices market is entering a phase of accelerated expansion, with an increase from USD 991.10 million in 2024 to USD 1.22 billion in 2025, reflecting a strong projected compound annual growth rate (CAGR) of 23.56% through 2032. By the end of this period, the market is estimated to reach USD 5.38 billion. Surging demand for real-time, dependable data streams is propelling adoption as healthcare organizations seek to digitize care delivery. Robust 5G infrastructure now forms the backbone of essential applications, ensuring seamless support for diagnostics, monitoring, and remote care. Investments in this technology are powering the modernization of clinical services across inpatient, outpatient, and home settings, with healthcare innovation increasingly driven by digital transformation.

Scope & Segmentation: 5G-Enabled Medical Devices Market

This report provides targeted analysis on how 5G adoption is guiding the evolution of medical devices, delivering strategic breakdowns that inform investment decisions across regions and technology categories. Segmentation is designed for clarity and practical application, enabling leaders to track trends and benchmark progress.

  • Product Types: Diagnostic equipment, such as imaging platforms and point-of-care systems, facilitates early detection and efficient evaluation. Monitoring solutions—covering cardiac, glucose, and respiratory functions—deliver continuous oversight, while therapeutic devices, including infusion pumps and neurostimulators, offer enhanced precision for chronic and acute care.
  • Applications: Uses span real-time asset tracking and emergency response optimization to remote patient management. The connectivity supports telemedicine platforms, boosts supply chain visibility, and implements smart hospital solutions, streamlining operations and extending care reach.
  • End Users: Hospitals, clinics, ambulatory surgical centers, homecare organizations, and telehealth providers integrate 5G-enabled devices to advance operational efficiency and enhance patient engagement across diverse care environments.
  • Connectivity Types: Key approaches include non-standalone and standalone 5G networks, private deployments, mmWave and sub-6 GHz options, each tailored to distinct performance, security, and scalability requirements.
  • Network Architectures: The ecosystem encompasses hybrid deployments, enterprise solutions, and offerings from public operators or mobile virtual network operators (MVNOs), all designed for flexible, secure integration in medical settings.
  • Components: Core hardware includes sensors, antennas, and modules. Services extend to consulting, integration, and ongoing maintenance, while software platforms handle analytics and device mobility management.
  • Regions: Dynamics differ across the Americas, Europe, Asia-Pacific, and Middle East & Africa, shaped by deployment velocity, the availability of digital health infrastructure, and varying demands for connected medical technology.
  • Company Coverage: Included analysis highlights established firms like General Electric Company, Siemens Healthineers AG, Koninklijke Philips N.V., Medtronic plc, Abbott Laboratories, and new entrants advancing medical device connectivity and system integration.

Key Takeaways for Senior Decision-Makers

  • Integrating 5G with medical devices enables connected workflows that link diagnostics, monitoring, and operational systems, improving care coordination in both acute and distributed settings.
  • Deploying private and hybrid 5G networks allows organizations to calibrate security protocols, supporting mission-critical applications and compliance with evolving regional health regulations.
  • Adopting open standards and modular device architectures improves adaptability, helping organizations respond to regulatory changes and supply chain variability without major technology overhauls.
  • Collaborations with telecommunications and analytics providers accelerate solution validation, supporting rapid scaling of telemedicine and management of chronic conditions.
  • Tailoring adoption strategies to local infrastructure and reimbursement environments ensures that entry and expansion align with operational realities and long-term market potential.
  • Granular segmentation enables targeted investment, allowing healthcare organizations to leverage connected health solutions in urgent response as well as ongoing chronic care management.

Tariff Impact: Navigating Cost Structures and Supply Chain Resilience

New and emerging tariffs in the United States have begun to affect sourcing and production costs for 5G-enabled medical devices. Manufacturers are strengthening ties with local suppliers, considering onshore and nearshore production, and using modular device designs to quickly adapt to changes. These strategies, supported by closer collaboration between device makers and telecommunications partners, reduce the risk of supply chain disruptions, helping organizations remain competitive in a complex trade landscape.

Methodology & Data Sources

This research leverages primary interviews with industry leaders, detailed consultations with subject matter experts, and secondary analysis of company reports and regulatory documents. Rigorous data triangulation ensures that insights are robust, actionable, and accurate to support critical decisions.

Why This Report Matters

  • Equips executives to pinpoint and seize high-value growth opportunities that drive healthcare digital transformation and integrate 5G advances effectively.
  • Empowers organizations to navigate regulatory adjustments and respond to the pace of technology adoption and global supply chain pressures through clear, actionable strategies.
  • Delivers tailored, region-specific insights and guidance, helping leaders allocate resources strategically and maximize returns in both established and high-growth healthcare markets.

Conclusion

5G integration into medical devices is redefining the healthcare environment. Forward-looking leaders who engage these trends will drive organizational transformation and enhance patient outcomes in the evolving digital health landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Integration of 5G connectivity in remote patient monitoring wearables for real-time data transmission
5.2. Deployment of 5G-enabled ultrasound probes to support high-definition mobile imaging in rural clinics
5.3. Adoption of network slicing for prioritizing critical patient data traffic in hospital 5G networks
5.4. Development of ultra-low latency 5G surgical robots to enable remote telesurgery with haptic feedback
5.5. Implementation of 5G-powered AI algorithms for predictive maintenance of in-hospital medical equipment
5.6. Integration of 5G-enabled telepharmacy solutions to support remote medication management in care homes
5.7. Use of 5G connectivity to stream continuous patient biometric data securely to cloud-based analytics platforms
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. 5G-enabled Medical Devices Market, by Product Type
8.1. Diagnostic Devices
8.1.1. Imaging Diagnostics
8.1.1.1. CT Scanners
8.1.1.2. MRI Scanners
8.1.1.3. Ultrasound Devices
8.1.2. Laboratory Diagnostics
8.1.2.1. Blood Analyzer
8.1.2.2. Urinalysis Analyzer
8.1.3. Point Of Care Diagnostics
8.2. Monitoring Devices
8.2.1. Cardiac Monitoring
8.2.1.1. Home Cardiac Monitoring
8.2.1.2. Hospital Cardiac Monitoring
8.2.2. Glucose Monitoring
8.2.2.1. Continuous Glucose Monitoring
8.2.2.2. Intermittent Glucose Monitoring
8.2.3. Respiratory Monitoring
8.2.3.1. Sleep Apnea Monitoring
8.2.3.2. Spirometry Monitoring
8.2.4. Vital Signs Monitoring
8.2.4.1. Blood Pressure Monitoring
8.2.4.2. Heart Rate Monitoring
8.2.4.3. Temperature Monitoring
8.3. Therapeutic Devices
8.3.1. Infusion Pumps
8.3.1.1. Insulin Infusion
8.3.1.2. Pain Management Infusion
8.3.2. Insulin Pumps
8.3.2.1. Patch Pumps
8.3.2.2. Tubed Pumps
8.3.3. Neurostimulators
8.3.3.1. Deep Brain Stimulators
8.3.3.2. Spinal Cord Stimulators
8.3.4. Respiratory Therapy Devices
8.3.4.1. CPAP Machines
8.3.4.2. Ventilators
9. 5G-enabled Medical Devices Market, by Application
9.1. Asset Tracking
9.1.1. Device Tracking
9.1.1.1. Equipment Positioning
9.1.1.2. Wearable Asset Tracking
9.1.2. Supply Chain Monitoring
9.1.2.1. Cold Chain Monitoring
9.1.2.2. Inventory Visibility
9.2. Emergency Response
9.2.1. Ambulance Services
9.2.1.1. Mobile Diagnostics
9.2.1.2. Prehospital Telehealth
9.2.2. Disaster Management
9.2.2.1. Field Hospital Enablement
9.2.2.2. Remote Coordination
9.3. Remote Patient Monitoring
9.3.1. Chronic Disease Management
9.3.1.1. Cardiac Care
9.3.1.2. Diabetes Management
9.3.2. Elderly Care
9.3.2.1. Activity Monitoring
9.3.2.2. Fall Detection
9.3.3. Postoperative Care
9.3.3.1. Pain Management
9.3.3.2. Wound Monitoring
9.4. Smart Hospital
9.4.1. Asset Management
9.4.1.1. Equipment Tracking
9.4.1.2. Inventory Management
9.4.2. Real-Time Location Services
9.4.2.1. Asset Tracking
9.4.2.2. Patient Tracking
9.4.3. Staff Management
9.4.3.1. Personnel Tracking
9.4.3.2. Workflow Optimization
9.5. Telemedicine
9.5.1. Emergency Teleconsultation
9.5.1.1. Ambulance Telehealth
9.5.1.2. Disaster Telecare
9.5.2. Video Consultation
9.5.2.1. AI-Assisted Diagnostics
9.5.2.2. Real-Time HD Video
9.5.3. Virtual ICU
9.5.3.1. Alarm Management
9.5.3.2. Remote Patient Surveillance
10. 5G-enabled Medical Devices Market, by End User
10.1. Ambulatory Surgical Centers
10.1.1. Hospital-Affiliated
10.1.2. Independent
10.2. Clinics
10.2.1. Outpatient Clinics
10.2.2. Specialty Clinics
10.3. Home Healthcare
10.3.1. Patient Homes
10.3.2. Senior Care Facilities
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
10.5. Telehealth Providers
10.5.1. Platform Providers
10.5.2. Service Aggregators
11. 5G-enabled Medical Devices Market, by Connectivity Type
11.1. NonStandalone 5G
11.1.1. MmWave
11.1.2. Sub6GHz
11.2. Private 5G
11.2.1. Campus Network
11.2.2. Industrial Network
11.3. Standalone 5G
11.3.1. MmWave
11.3.2. Sub6GHz
12. 5G-enabled Medical Devices Market, by Network Architecture
12.1. Hybrid Network
12.1.1. Edge Integrated
12.1.2. On-Premise Core
12.2. Private Network
12.2.1. Campus Network
12.2.2. Enterprise Network
12.3. Public Network
12.3.1. MVNO
12.3.2. Operator Network
13. 5G-enabled Medical Devices Market, by Component
13.1. Hardware
13.1.1. Antennas
13.1.2. Modules
13.1.2.1. Connectivity Modules
13.1.2.2. Power Modules
13.1.3. Sensors
13.2. Services
13.2.1. Consulting Services
13.2.2. Integration Services
13.2.3. Maintenance Services
13.3. Software
13.3.1. Analytics Software
13.3.2. Mobility Applications
13.3.3. Platforms
14. 5G-enabled Medical Devices Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. 5G-enabled Medical Devices Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. 5G-enabled Medical Devices Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. General Electric Company
17.3.2. Siemens Healthineers AG
17.3.3. Koninklijke Philips N.V.
17.3.4. Medtronic plc
17.3.5. Johnson & Johnson
17.3.6. Abbott Laboratories
17.3.7. Becton, Dickinson and Company
17.3.8. Baxter International Inc.
17.3.9. Boston Scientific Corporation
17.3.10. Samsung Electronics Co., Ltd

Companies Mentioned

The companies profiled in this 5G-enabled Medical Devices market report include:
  • General Electric Company
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Johnson & Johnson
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Baxter International Inc.
  • Boston Scientific Corporation
  • Samsung Electronics Co., Ltd

Table Information